Lancet. 1998 Jul 25;352(9124):314-6.

1998 revision to the British HIV Association guidelines for antiretroviral treatment of HIV seropositive individuals. BHIVA Guidelines Writing Committee.

Source

St Stephen's Clinic, Chelsea and Westminster Hospital, London, UK.

Erratum in

Lancet 1998 Oct 24;352(9137):1394.

Abstract

When the British HIV-1 Association (BHIVA) guidelines on the treatment of HIV-seropositive individuals with antiretrovirals were published in The Lancet in April 1997, it was clear that they would require updating on a frequent basis. The guidelines have been useful in ensuring that viral-load testing and combination therapy is widely available in the UK. However, standards of treatment are rapidly changing as new evidence becomes available. Since formulation of the guidelines, data from two large clinical endpoint studies have been presented that show superior clinical benefit for the use of triple therapy compared with dual therapy in treatment of both naive individuals and patients who have been given zidovudine. Here we update the BHIVA guidelines with a consensus drawn from a wide range of UK medical opinion. The guidelines include input from groups representing individuals living with HIV-1. A more detailed reflection of these views may be found in publications such as the National AIDS Manual and the AIDS Treatment Project's Doctor fax.

Comment in

PMID:: 9690427; [PubMed - indexed for MEDLINE]

Publication Types, MeSH Terms, Substances

Publication Types

MeSH Terms

Substances

LinkOut - more resources

Full Text Sources

Medical

Supplemental Content

Related citations

Review British HIV Association guidelines for antiretroviral treatment of HIV seropositive individuals. BHIVA Guidelines Co-ordinating Committee. [Lancet. 1997]
Review British HIV Association guidelines for antiretroviral treatment of HIV seropositive individuals. BHIVA Guidelines Co-ordinating Committee.
. Lancet. 1997 Apr 12; 349(9058):1086-92.
Findings from the British HIV Association's national clinical audit of first-line antiretroviral therapy and survey of treatment practice and maternity care, 2002. [HIV Med. 2004]
Findings from the British HIV Association's national clinical audit of first-line antiretroviral therapy and survey of treatment practice and maternity care, 2002.
Brook MG, Curtis H, Johnson MA, British HIV Association Clinical Audit Committee. HIV Med. 2004 Nov; 5(6):415-20.
British HIV Association (BHIVA) guidelines for the treatment of HIV-infected adults with antiretroviral therapy. [HIV Med. 2000]
British HIV Association (BHIVA) guidelines for the treatment of HIV-infected adults with antiretroviral therapy.
BHIVA Writing Committee, BHIVA Executive Committee. HIV Med. 2000 Mar; 1(2):76-101.
British HIV Association (BHIVA) guidelines for the treatment of HIV-infected adults with antiretroviral therapy. [HIV Med. 2003]
British HIV Association (BHIVA) guidelines for the treatment of HIV-infected adults with antiretroviral therapy.
Pozniak A, Gazzard B, Anderson J, Babiker A, Churchill D, Collins S, Fisher M, Johnson M, Khoo S, Leen C, et al. HIV Med. 2003 Oct; 4 Suppl 1:1-41.
Review Tipranavir: PNU 140690, tipranivir. [Drugs R D. 2006]
Review Tipranavir: PNU 140690, tipranivir.
. Drugs R D. 2006; 7(1):55-62.

See reviews... See all...

Cited by 7 PubMed Central articles

The changing epidemiology of prevalent diagnosed HIV infections in England, Wales, and Northern Ireland, 1997 to 2003. [Sex Transm Infect. 2005]
The changing epidemiology of prevalent diagnosed HIV infections in England, Wales, and Northern Ireland, 1997 to 2003.
Rice BD, Payne LJ, Sinka K, Patel B, Evans BG, Delpech V. Sex Transm Infect. 2005 Jun; 81(3):223-9.
Impact of NNRTI compared to PI-based highly active antiretroviral therapy on CCR5 receptor expression, beta-chemokines and IL-16 secretion in HIV-1 infection. [Clin Exp Immunol. 2002]
Impact of NNRTI compared to PI-based highly active antiretroviral therapy on CCR5 receptor expression, beta-chemokines and IL-16 secretion in HIV-1 infection.
Burton CT, Hardy GA, Sullivan AK, Nelson MR, Gazzard B, Gotch FM, Imami N. Clin Exp Immunol. 2002 Nov; 130(2):286-92.
Hepatitis B, lamivudine, and HIV. [BMJ. 2001]
Hepatitis B, lamivudine, and HIV.
Kuchimanchi U, Rooney G. BMJ. 2001 Jul 7; 323(7303):51.

See all...

Related information

Related Citations
Calculated set of PubMed citations closely related to the selected article(s) retrieved using a word weight algorithm. Related articles are displayed in ranked order from most to least relevant, with the “linked from” citation displayed first.
Cited in PMC
Full-text articles in the PubMed Central Database that cite the current articles.

Recent activity

Clear Turn Off Turn On

1998 revision to the British HIV Association guidelines for antiretroviral treat...
1998 revision to the British HIV Association guidelines for antiretroviral treatment of HIV seropositive individuals. BHIVA Guidelines Writing Committee.
Lancet. 1998 Jul 25 ;352(9124):314-6.

PubMed
Increasing implicit self-esteem through classical conditioning.
Increasing implicit self-esteem through classical conditioning.
Psychol Sci. 2004 Jul ;15(7):498-502.

PubMed
How to heat up from the cold: examining the preconditions for (unconscious) mood...
How to heat up from the cold: examining the preconditions for (unconscious) mood effects.
J Pers Soc Psychol. 2008 May ;94(5):777-91.

PubMed
I like myself but I don't know why: enhancing implicit self-esteem by subliminal...
I like myself but I don't know why: enhancing implicit self-esteem by subliminal evaluative conditioning.
J Pers Soc Psychol. 2004 Feb ;86(2):345-55.

PubMed
Parafoveal words are effective in both hemifields: preattentive processing of se...
Parafoveal words are effective in both hemifields: preattentive processing of semantic and phonological codes.
Perception. 1983 ;12(2):213-21.

PubMed

Your browsing activity is empty.

Activity recording is turned off.

Turn recording back on

PubMed

Display Settings:

Send to: